Literature DB >> 28478513

FRET studies of various conformational states adopted by transthyretin.

Seyyed Abolghasem Ghadami1, Francesco Bemporad1, Benedetta Maria Sala2, Guido Tiana3, Stefano Ricagno2, Fabrizio Chiti4.   

Abstract

Transthyretin (TTR) is an extracellular protein able to deposit into well-defined protein aggregates called amyloid, in pathological conditions known as senile systemic amyloidosis, familial amyloid polyneuropathy, familial amyloid cardiomyopathy and leptomeningeal amyloidosis. At least three distinct partially folded states have been described for TTR, including the widely studied amyloidogenic state at mildly acidic pH. Here, we have used fluorescence resonance energy transfer (FRET) experiments in a monomeric variant of TTR (M-TTR) and in its W41F and W79F mutants, taking advantage of the presence of a unique, solvent-exposed, cysteine residue at position 10, that we have labelled with a coumarin derivative (DACM, acceptor), and of the two natural tryptophan residues at positions 41 and 79 (donors). Trp41 is located in an ideal position as it is one of the residues of β-strand C, whose degree of unfolding is debated. We found that the amyloidogenic state at low pH has the same FRET efficiency as the folded state at neutral pH in both M-TTR and W79F-M-TTR, indicating an unmodified Cys10-Trp41 distance. The partially folded state populated at low denaturant concentrations also has a similar FRET efficiency, but other spectroscopic probes indicate that it is distinct from the amyloidogenic state at acidic pH. By contrast, the off-pathway state accumulating transiently during refolding has a higher FRET efficiency, indicating non-native interactions that reduce the Cys10-Trp41 spatial distance, revealing a third distinct conformational state. Overall, our results clarify a negligible degree of unfolding of β-strand C in the formation of the amyloidogenic state and establish the concept that TTR is a highly plastic protein able to populate at least three distinct conformational states.

Entities:  

Keywords:  FAC; FAP; Folding intermediate; Protein aggregation; Protein folding; Protein misfolding; SSA

Mesh:

Substances:

Year:  2017        PMID: 28478513     DOI: 10.1007/s00018-017-2533-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  49 in total

1.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

2.  FRET study of membrane proteins: simulation-based fitting for analysis of membrane protein embedment and association.

Authors:  Petr V Nazarov; Rob B M Koehorst; Werner L Vos; Vladimir V Apanasovich; Marcus A Hemminga
Journal:  Biophys J       Date:  2006-04-21       Impact factor: 4.033

3.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

Review 4.  Fluorescence resonance energy transfer.

Authors:  R M Clegg
Journal:  Curr Opin Biotechnol       Date:  1995-02       Impact factor: 9.740

5.  Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.

Authors:  Roberta Cascella; Simona Conti; Benedetta Mannini; Xinyi Li; Joel N Buxbaum; Bruno Tiribilli; Fabrizio Chiti; Cristina Cecchi
Journal:  Biochim Biophys Acta       Date:  2013-09-25

6.  Localization of transthyretin-mRNA and of immunoreactive transthyretin in the human fetus.

Authors:  B Jacobsson
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  Transthyretin immunoreactivity in human and porcine liver, choroid plexus, and pancreatic islets.

Authors:  B Jacobsson; V P Collins; L Grimelius; T Pettersson; B Sandstedt; A Carlström
Journal:  J Histochem Cytochem       Date:  1989-01       Impact factor: 2.479

8.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  BALBES: a molecular-replacement pipeline.

Authors:  Fei Long; Alexei A Vagin; Paul Young; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-12-05
View more
  3 in total

1.  Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers.

Authors:  Anvesh K R Dasari; Robert M Hughes; Sungsool Wi; Ivan Hung; Zhehong Gan; Jeffrey W Kelly; Kwang Hun Lim
Journal:  Sci Rep       Date:  2019-01-10       Impact factor: 4.379

2.  Probing conformational changes of monomeric transthyretin with second derivative fluorescence.

Authors:  Denisa Jazaj; Seyyed Abolghasem Ghadami; Francesco Bemporad; Fabrizio Chiti
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

3.  Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers.

Authors:  Seyyed Abolghasem Ghadami; Sean Chia; Francesco Simone Ruggeri; Georg Meisl; Francesco Bemporad; Johnny Habchi; Roberta Cascella; Christopher M Dobson; Michele Vendruscolo; Tuomas P J Knowles; Fabrizio Chiti
Journal:  Biomacromolecules       Date:  2020-02-17       Impact factor: 6.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.